Baker Hughes A GE Co. buy BiotechBee
Start price
27.10.22
/
60%
€27.00
Target price
31.05.24
€35.00
Performance (%)
0.65%
End price
21.12.22
€27.17
Summary
This prediction ended on 21.12.22 with a price of €27.17. The BUY prediction by BiotechBee for Baker Hughes A GE Co. closed nearly unchanged. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Baker Hughes A GE Co. | -0.844% | -0.844% | 40.532% | 62.185% |
| iShares Core DAX® | 2,33 % | 1,01 % | 10,41 % | 61,23 % |
| iShares Nasdaq 100 | 1,37 % | -3,61 % | 27,40 % | 80,08 % |
| iShares Nikkei 225® | 2,44 % | -7,46 % | 49,84 % | 72,35 % |
| iShares S&P 500 | 1,26 % | 0,68 % | 23,67 % | 65,89 % |
According to BiotechBee what are the pros and cons of Baker Hughes A GE Co. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Baker Hughes A GE Co. diskutieren
Buy mit Kursziel 35,0
In the thread Trading Baker Hughes A GE Co.
Buy beendet

